MEDROXYPROGESTERONE ACETATE Recall D-1145-2022
Description: medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 62756-091-40.
MEDROXYPROGESTERONE ACETATE Recall D-1145-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-1145-2022 |
Event ID | 90151 |
Brand | MEDROXYPROGESTERONE ACETATE |
Generic Name | MEDROXYPROGESTERONE ACETATE |
Manufacturer | MEDROXYPROGESTERONE ACETATE |
Original Package? | 1 |
Active Substance | MEDROXYPROGESTERONE ACETATE |
Drug Route | INTRAMUSCULAR |
Distribution | USA Nationwide |
Quantity | 4625 syringes |
Recall Reason | Lack of assurance of sterility |
Drug Classification | Class II |
Drug Code Info | 20220622 |
Product NDC | 62756-091 |
Recall Initiation Date | 20220506 |
Report Date | 20220622 |
Classification Date | 20220610 |
Address | 2 Independence Way Princeton, NJ 08540-6620 United States |
Recalling Firm | SUN PHARMACEUTICAL INDUSTRIES INC |
Unique Ingredient Identifier | C2QI4IOI2G |
Drug Application Number | ANDA210761 |
Structured Product Labeling (SPL ID) | 8524701e-5f25-4a0a-a923-5e34911827a4 |
Structured Product Labeling (SPL Set ID) | 01e28bef-9758-40cf-a4ff-86ae9f4f5105 |
Similar To |